Aberrant crypt foci: Difference between revisions
CSV import |
CSV import Tags: Reverted mobile edit mobile web edit |
||
| Line 14: | Line 14: | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Revision as of 03:10, 17 March 2025
abemaciclib (uh-BEH-muh-SY-klib)A drug used to treat hormone-receptor positive (HR+), HER2-negative (HER2-) breast cancer that is advanced or has spread to other parts of the body.
Used with aromase inhinitors
It is used with an aromatase inhibitor in postmenopausal women who have not been treated with hormone therapy. It is used with fulvestrant in women whose disease got worse after treatment with hormone therapy. Abemaciclib is also used alone in men and women whose disease got worse after treatment with hormone therapy and previous chemotherapy. It is also being studied in the treatment of other types of cancer. Abemaciclib blocks certain proteins, which may help keep cancer cells from growing.
Cyclin dependent kinase inhibitor
It is a type of cyclin-dependent kinase inhibitor.
Other names
Also called Verzenio.



